NASDAQ · Financial Statements

Rapport Therapeutics, Inc. (RAPP) Financial Statements

$30.76 NASDAQ: RAPP Market Cap $1.47B

Rapport Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-111.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$0
Operating Profit$-10.0M$-36.0M$-83.0M$-125.0M
Net Profit$-11.0M$-35.0M$-78.0M$-111.0M
EPS$-0.29$-0.95$-3.78$-2.86
Op Margin————

Balance Sheet (USD)

Metric2022202320242025
Total Assets$32.0M$155.0M$315.0M$512.0M
Total Liabilities$12.0M$181.0M$10.0M$28.0M
Cash$31.0M$70.0M$57.0M$53.0M
Borrowings$10.0M$2.0M$1.0M$11.0M

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-3.0M$-27.0M$-65.0M$-87.0M
Investing Cash Flow$-6.0M$-80.0M$-173.0M$-188.0M
Financing Cash Flow$0$0$0$0
Net Cash Flow$31.0M$39.0M$-13.0M$-4.0M
Free Cash Flow$-4.0M$-29.0M$-67.0M$-88.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.48
EV / EBITDA-9.82
FCF Yield-6.44%
Quick Ratio15.72
Interest Coverage0.00
Return 1Y166.97%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
RAPP Overview RAPP Dividend Run Stock Screener